Myocarditis Acute
19
7
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 19 trials
100.0%
+13.4% vs benchmark
16%
3 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (19)
MCE Molecular Imaging for Myocarditis
Abatacept in Immune Checkpoint Inhibitor Myocarditis
One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute Myocarditis
Arrhythmic Risk in Myocarditis Outcome Research
Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis
French Registry of CMR Late Gadolinium Enhancement in Myocarditis
Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital
MYTHS - MYocarditis THerapy With Steroids
CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance
Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort
Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis
Ventricular Arrhythmia After Myocarditis in Sportsman
Role of Spectral CT in the Diagnosis of Myocarditis/MINOCA in Patients Undergoing cardioCT Investigations for Acute Chest Pain
Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
Multicenter Retrospective Observational Study of Acute Myocarditis in Korea
Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis
Evaluation of Long-term Incidence of Ventricular Arrhythmias in Patients With Acute Myocarditis
Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19